158 related articles for article (PubMed ID: 7884586)
1. Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression.
Kerr KM; Carey FA; King G; Lamb D
J Pathol; 1994 Dec; 174(4):249-56. PubMed ID: 7884586
[TBL] [Abstract][Full Text] [Related]
2. Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.
Kitamura H; Kameda Y; Nakamura N; Nakatani Y; Inayama Y; Iida M; Noda K; Ogawa N; Shibagaki T; Kanisawa M
Am J Pathol; 1995 Apr; 146(4):876-87. PubMed ID: 7717455
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of pulmonary atypical alveolar cell hyperplasia in an autopsy population: a study of 100 cases.
Sterner DJ; Mori M; Roggli VL; Fraire AE
Mod Pathol; 1997 May; 10(5):469-73. PubMed ID: 9160312
[TBL] [Abstract][Full Text] [Related]
4. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
[TBL] [Abstract][Full Text] [Related]
5. The association between atypical adenomatous hyperplasia and primary lung cancer.
Chapman AD; Kerr KM
Br J Cancer; 2000 Sep; 83(5):632-6. PubMed ID: 10944604
[TBL] [Abstract][Full Text] [Related]
6. Survivin expression in atypical adenomatous hyperplasia of the lung.
Nakanishi K; Kawai T; Kumaki F; Hiroi S; Mukai M; Ikeda E
Am J Clin Pathol; 2003 Nov; 120(5):712-9. PubMed ID: 14608897
[TBL] [Abstract][Full Text] [Related]
7. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
[TBL] [Abstract][Full Text] [Related]
9. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
[TBL] [Abstract][Full Text] [Related]
10. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
11. The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms.
Ruffini E; Bongiovanni M; Cavallo A; Filosso PL; Giobbe R; Mancuso M; Molinatti M; Oliaro A
Eur J Cardiothorac Surg; 2004 Jul; 26(1):165-72. PubMed ID: 15200997
[TBL] [Abstract][Full Text] [Related]
12. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung.
Mori M; Rao SK; Popper HH; Cagle PT; Fraire AE
Mod Pathol; 2001 Feb; 14(2):72-84. PubMed ID: 11235908
[TBL] [Abstract][Full Text] [Related]
13. Precursor lesions of adenocarcinoma lung--two case reports.
Jain D; Joshi K; Jindal SK
Indian J Pathol Microbiol; 2005 Jul; 48(3):399-402. PubMed ID: 16761769
[TBL] [Abstract][Full Text] [Related]
14. Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia.
Koga T; Hashimoto S; Sugio K; Yonemitsu Y; Nakashima Y; Yoshino I; Matsuo Y; Mojtahedzadeh S; Sugimachi K; Sueishi K
Am J Clin Pathol; 2002 Mar; 117(3):464-70. PubMed ID: 11888087
[TBL] [Abstract][Full Text] [Related]
15. Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma.
Hayashi H; Miyamoto H; Ito T; Kameda Y; Nakamura N; Kubota Y; Kitamura H
Am J Pathol; 1997 Aug; 151(2):461-70. PubMed ID: 9250158
[TBL] [Abstract][Full Text] [Related]
16. [Atypical adenomatous hyperplasia of the lung].
Paklina OV; Galil-Ogly GA; Bershchanskaia AM; Alipchenko LA
Arkh Patol; 2000; 62(3):21-4. PubMed ID: 10897432
[TBL] [Abstract][Full Text] [Related]
17. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics.
Mori M; Tezuka F; Chiba R; Funae Y; Watanabe M; Nukiwa T; Takahashi T
Cancer; 1996 Feb; 77(4):665-74. PubMed ID: 8616758
[TBL] [Abstract][Full Text] [Related]
18. C-erbB-2 oncoprotein expression in operable non-small cell lung cancer.
Giatromanolaki A; Gorgoulis V; Chetty R; Koukourakis MI; Whitehouse R; Kittas C; Veslemes M; Gatter KC; Iordanoglou I
Anticancer Res; 1996; 16(2):987-93. PubMed ID: 8687165
[TBL] [Abstract][Full Text] [Related]
19. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content.
Nakayama H; Noguchi M; Tsuchiya R; Kodama T; Shimosato Y
Mod Pathol; 1990 May; 3(3):314-20. PubMed ID: 2362938
[TBL] [Abstract][Full Text] [Related]
20. Value of c-erbB-2 and p53 oncoprotein co-overexpression in human breast cancer.
Barbati A; Cosmi EV; Sidoni A; Collini P; Porpora MG; Ferri I; Lüthy M; Lauro V; Bucciarelli E
Anticancer Res; 1997; 17(1A):401-5. PubMed ID: 9066684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]